Recent Crohn’s Disease Market Data reveals that the demand for advanced biologics and small-molecule drugs is escalating rapidly. Data from clinical trials indicate higher remission rates among patients treated with biologics compared to traditional therapies. Global healthcare expenditure dedicated to inflammatory bowel diseases has grown by double digits annually, reflecting expanding...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt